Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
GVS, the Italian manufacturer of filters and components for among other groups, healthcare companies, is on track to list in Milan this summer, according to sources close to the deal. The company is likely to be the first major listing on the Italian exchange this year after Covid-19 froze the market. -
GlaxoSmithKline, the UK pharmaceutical company, launched a three tranche bond issue on Monday. Its sterling curve was trading so flat that it started with the same spread on the long eight and 15 year tranches.
-
QBE sold $500m of additional tier one debt in the dollar market this week, as it sought to shield itself from the financial impact of the coronavirus pandemic.
-
This week's funding scorecard looks at the progress European sovereigns have made in their funding programmes at the start of May.
-
The Republic of Peru has approved a further $4bn of debt issuance to finance coronavirus spending just two weeks after tapping bond markets for $3bn.
-
Norwegian Air Shuttle is close to receiving vital loan guarantees from Norway, as shareholders voted through a near $1bn-equivalent debt to equity swap from bondholders and aircraft lessors.
